1 North Wealth Services’s Inovio Pharmaceuticals INO Stock Holding History

1 North Wealth Services’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45	Hold	41	–	–	﹤0.01%	307
2026 Q1	$71	Hold	41	–	–	﹤0.01%	267
2025 Q4	$71	Hold	41	–	–	﹤0.01%	277
2025 Q3	$96	Hold	41	–	–	﹤0.01%	255
2025 Q2	$83	Hold	41	–	–	﹤0.01%	263
2025 Q1	$67	Buy	+41	New	+$82	﹤0.01%	264

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

1 North Wealth Services's INO Position: Q2 2026 in Review

1 North Wealth Services held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 41 shares worth $45. The position accounts for ﹤0.01% of the portfolio, ranked #307.

1 North Wealth Services first reported a position in INO in Q1 2025 and has held it in 6 quarters since. The position peaked at $96 in Q3 2025. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

1 North Wealth Services held 41 shares of Inovio Pharmaceuticals worth $45 as of Q2 2026.
1 North Wealth Services left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of 1 North Wealth Services's portfolio in Q2 2026, its #307 holding.
1 North Wealth Services first reported a position in Inovio Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
1 North Wealth Services's Inovio Pharmaceuticals position peaked at $96 in Q3 2025.
102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on 1 North Wealth Services's 13F filing for Q2 2026, filed 3 Aug 2026.